Maxigen Biotech Inc. total revenue, net income and dynamics of changes in Taiwan new dollar today
Maxigen Biotech Inc. current income and income for the latest reporting periods. Net revenue Maxigen Biotech Inc. is now 111 009 000 $. Information about net revenue is taken from open sources. Net income of Maxigen Biotech Inc. today amounted to 21 620 000 $. The financial graph of Maxigen Biotech Inc. shows the values and changes of such indicators: total assets, net income, net revenue. The financial report chart on our website displays information by dates from 31/12/2018 to 31/03/2021. Maxigen Biotech Inc. net income is shown in blue on the graph.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
111 009 000 $
+20.35 % ↑
21 620 000 $
+218.22 % ↑
31/12/2020
122 922 000 $
+30.69 % ↑
20 392 000 $
+176.28 % ↑
30/09/2020
115 073 000 $
-4.621 % ↓
12 199 000 $
-37.412 % ↓
30/06/2020
116 370 000 $
-8.7029 % ↓
20 534 000 $
-22.105 % ↓
30/09/2019
120 648 000 $
-
19 491 000 $
-
30/06/2019
127 463 000 $
-
26 361 000 $
-
31/03/2019
92 236 000 $
-
6 794 000 $
-
31/12/2018
94 055 000 $
-
7 381 000 $
-
Show:
to
Maxigen Biotech Inc. financial report charts
The dates of the latest financial statements of Maxigen Biotech Inc.: 31/12/2018, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest financial report of Maxigen Biotech Inc. is available online for such a date - 31/03/2021. Gross profit Maxigen Biotech Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Maxigen Biotech Inc. is 60 085 000 $
Maxigen Biotech Inc. quarterly report dates
Cost of revenue Maxigen Biotech Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Maxigen Biotech Inc. is 50 924 000 $ Total revenue Maxigen Biotech Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Maxigen Biotech Inc. is 111 009 000 $ Operating income Maxigen Biotech Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Maxigen Biotech Inc. is 21 522 000 $
Net income Maxigen Biotech Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Maxigen Biotech Inc. is 21 620 000 $ Current assets Maxigen Biotech Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Maxigen Biotech Inc. is 459 893 000 $ Total assets Maxigen Biotech Inc. refers to the total amount of assets owned by a person or entity. Total assets Maxigen Biotech Inc. is 977 366 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
60 085 000 $
62 385 000 $
53 710 000 $
53 234 000 $
58 208 000 $
64 530 000 $
37 284 000 $
44 169 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
50 924 000 $
60 537 000 $
61 363 000 $
63 136 000 $
62 440 000 $
62 933 000 $
54 952 000 $
49 886 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
111 009 000 $
122 922 000 $
115 073 000 $
116 370 000 $
120 648 000 $
127 463 000 $
92 236 000 $
94 055 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
120 648 000 $
127 463 000 $
92 236 000 $
94 055 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
21 522 000 $
24 837 000 $
12 252 000 $
15 282 000 $
25 042 000 $
27 189 000 $
1 457 000 $
1 185 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
21 620 000 $
20 392 000 $
12 199 000 $
20 534 000 $
19 491 000 $
26 361 000 $
6 794 000 $
7 381 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
16 607 000 $
16 628 000 $
20 158 000 $
17 360 000 $
13 398 000 $
16 111 000 $
14 599 000 $
20 285 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
89 487 000 $
98 085 000 $
102 821 000 $
101 088 000 $
95 606 000 $
100 274 000 $
90 779 000 $
92 870 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
459 893 000 $
432 058 000 $
402 982 000 $
440 306 000 $
608 242 000 $
644 365 000 $
600 914 000 $
599 525 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
977 366 000 $
956 470 000 $
930 842 000 $
975 966 000 $
1 155 679 000 $
1 196 173 000 $
1 154 402 000 $
1 135 457 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
201 591 000 $
209 762 000 $
148 981 000 $
141 635 000 $
172 393 000 $
211 534 000 $
216 802 000 $
184 844 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
298 935 000 $
358 401 000 $
76 947 000 $
79 254 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
311 802 000 $
371 923 000 $
91 116 000 $
79 343 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
26.98 %
31.09 %
7.89 %
6.99 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
881 875 000 $
860 227 000 $
840 084 000 $
827 963 000 $
837 076 000 $
817 449 000 $
842 913 000 $
836 178 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
36 328 000 $
-8 748 000 $
15 575 000 $
34 323 000 $
Last revenue report of Maxigen Biotech Inc. was 31/03/2021. According to last financial report total revenue in Maxigen Biotech Inc. was 111 009 000 Taiwan new dollar and changed by +20.35% since last year. Net income in Maxigen Biotech Inc. was 21 620 000 $ in last quartal, net income changes to +218.22%.
Current cash Maxigen Biotech Inc. - the sum of all of the cash a company has on the date of report. Current cash Maxigen Biotech Inc. is 201 591 000 $
Maxigen Biotech Inc. stocks data
1783.TW stock price
Maxigen Biotech Inc. stock price today, 1783.TW stock quote.
